Cardiac Science Corp (NASDAQ:CSCX)

CAPS Rating: No stars

The Company develops, manufactures and markets a family of advanced diagnostic and therapeutic cardiology devices.

Results 1 - 6 of 6

Recs

0
Member Avatar 1870bill (< 20) Submitted: 10/20/2008 12:47:01 AM : Underperform Start Price: $9.10 CSCX Score: +116.51

It's been going side ways for so long I don't expect it to change without a miracle.

Recs

0
Member Avatar porcelain808 (34.28) Submitted: 5/4/2008 10:16:02 PM : Outperform Start Price: $9.05 CSCX Score: -71.49

Good fins/funds. Mod growth.

Recs

1
Member Avatar ELDUQUE719 (< 20) Submitted: 4/3/2008 12:23:38 AM : Underperform Start Price: $8.12 CSCX Score: +72.16

with pe ratio over 20. I dont see value in here and not much return

Recs

0
Member Avatar Willie97 (< 20) Submitted: 3/3/2008 2:29:00 PM : Outperform Start Price: $9.09 CSCX Score: -78.11

Almost all the baby boomers have heart problems, this company makes all the equipment to save their lives and monitor their recovery.

Recs

0
Member Avatar NeroSagetrade (91.74) Submitted: 1/2/2008 2:09:42 AM : Outperform Start Price: $8.10 CSCX Score: -65.31

Cardiac Sciences is getting used and abused for no particular reason and now is the time to buy. CSCX is trading at 26 times forward earnings, has successfully beaten analysts earnings estimates over the past year, is trading at 0.8 times book value, and raised revenue guidance when they reported their most recent quarterly earnings. Things are going great for CSCX thanks in part to their huge revenue jump in defibrilation devices. They have no debt and nearly 17 million in cash. I don't get what the problem is here. Cooler heads will prevail.

Nero

Sagetrade

Recs

0
Member Avatar ld4runner (48.80) Submitted: 4/27/2007 2:23:06 PM : Outperform Start Price: $10.56 CSCX Score: -71.34

Owned this stock when it was DFIB. I'm back because it's on the way up. It's that simple.

Results 1 - 6 of 6

Featured Broker Partners


Advertisement